Skip to main content
Equibles

Holocene Advisors, LP

Position in ARQT — Arcutis Biotherapeutics, Inc.

CIK 1700574 New York, NY
Back to ARQT Full portfolio

Position in ARQT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$4,293,053
-$2,103,043 QoQ
Shares Held
163,732
-86.4% QoQ
Ownership
0.130%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#79
of 271 holders
Holding Since
Sep 2022
6 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ARQT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Holocene Advisors, LP holds $1,266,200,483 across 29 Biotechnology names. ARQT ranks #19 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 1,359,269 $254,563,898
2 DNLI
Denali Therapeutics Inc.
 3,905,225 $100,442,387
3 CYTK
Cytokinetics Inc
 1,144,579 $97,506,685
4 SRRK
Scholar Rock Holding Corp
 1,755,978 $96,578,790
5 ARWR
Arrowhead Pharmaceuticals, Inc.
 1,106,177 $90,164,487
6 SYRE
Spyre Therapeutics, Inc.
 1,015,170 $90,126,792
7 MDGL
Madrigal Pharmaceuticals, Inc.
 152,924 $82,112,541
8 TNGX
Tango Therapeutics, Inc.
 2,410,939 $75,365,953

All Filings in ARQT

Export CSV
6 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,293,053 163,732
2023-09-30 $6,396,096 1,204,538
2023-06-30 $13,723,543 1,440,036
2023-03-31 $22,760,947 2,069,177
2022-12-31 $16,948,116 1,145,143
2022-09-30 $2,694,548 141,002